Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Biography: Dr A.O. Olowofolahan had his first degree in Biochemistry from Obafemi Awolowo University, Ile-Ife, Osun State after which he proceeded to University of Ibadan for his Masters and Doctorate degree in Biochemistry. He holds a faculty position as a Lecturer I in the department of Biochemistry, University of Ibadan, Nigeria. Dr A.O. Olowofolahan was a recipient of Tertiary Education Trust Fund Award (TETFUND) (2017) tenable at Department of Biological Sciences, Davie campus, Florida Atlantic University, Florida, United States of America (USA) with Professor James Kumi-Diaka. Also, a recipient of Association of Commonwealth Universities (ACU) Early Career Conference Grant (2022) tenable at 3rd International Conference on Cell and Experimental Biology (CEB-2022) April 18-20, 2022, Boston, MA, USA. His area of research focus includes mitochondria, apoptosis, cancer, phytotherapy and drug development. He is currently working on the biochemical and molecular mechanisms of action of some selected isolated and naturally occurring compounds with respect to their pharmacological potential in female gynaecological disorder; such as uterine fibroid, endometrial hyperplasia and polycystic ovary syndrome. He is a member of Nigeria Society for Experimental Biology (NISEB), Nigerian Society of Biochemistry and Molecular Biology, Biochemical Society, UK and World Mitochondria Society. He has about twenty-three publications in reputable international peer-reviewed journals. Current Research 1. Title: Antiproliferative potential of purified compounds from chloroform fraction of Drymaria cordata on uterine myoma cells and rat model 1. Effect of different fractions of methanol extract of Drymaria cordata on mitochondrial-mediated apoptosis 2. Ameliorative potential of methanol extract and chloroform fraction of Drymaria cordata on monosodium glutamate-induced uterine hyperplasia in female rats Selected Publications Facebook: Profile Link Profile
Name:Adeola O. OLOWOFOLAHAN
Designation: Lecturer I
Faculty: Basic Medical Sciences
Department: Biochemistry
ORCID Profile
Alternate Email Address 1: This email address is being protected from spambots. You need JavaScript enabled to view it.
Alternate Email Address 2: This email address is being protected from spambots. You need JavaScript enabled to view it.
Research
Funder: NIH
Nil Uterine myoma (UM) is the most frequent benign tumor in women and is responsible for menorrhagia and other forms of abnormal uterine disorder. The pathogenesis of UM may be related to sex hormones and their receptors, cell proliferation and apoptosis, abnormal signal transduction pathways, molecular genetics and other factors. Studies have shown that some bioactive agents isolated from natural sources elicit chemopreventive and therapeutic properties against tumors and cancers. Drymaria cordata (Caryophyllaceae) is a medicinal plant used in the traditional treatment of uterine fibroid and breast tumor in Nigeria. In our previous study, we found that methanol extract of Drymaria cordata and its various fractions induced mitochondrial-mediated apoptosis in rat model with the chloroform fraction being the most potent (Olowofolahan et al., 2015; Olowofolahan and Olorunsogo, 2018). Also, we have been able to demonstrate the antiproliferative potential of the methanol extract and chloroform fraction in monosodium glutamate-induced uterine hyperplasia (Olowofolahan et al., 2017). However, the putative compound(s) and the underlying mechanisms have not been fully explored; thus; the reason for this study.
Role: Investigator
Collaborators:
Completed ResearchPublications
Social Media Handle
Pintrest: Profile Link
LinkedIn: Profile Link
Instagram: Profile Link
YouTube: Profile Link
Dr. Adeola O. OLOWOFOLAHAN
Twitter: Profile Link